# Phase 2 studies of oral hypoxia-inducible factor prolyl hydroxylase inhibitor FG-4592 for treatment of anemia in China

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/phase-2-studies-of-oral-hypoxia-inducible-factor-prolyl-hydroxylase-inhibitor-fg/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Nan Chen,Jiaqi Qian,Jianghua Chen,Xueqing Yu,Changlin Mei,Chuan‐Ming Hao,Gengru Jiang,Hongli Lin,Xinzhou Zhang,Li Zuo,Qiang He,Ping Fu,Xuemei Li,Dalvin Ni,Stefan Hemmerich,Cameron Liu,Lynda A. Szczech,Anatole Besarab,Thomas B. Neff,Kin-Hung P. Yu,Frank H. Valone |
| Citations | 200 |
| DOI | 10.1093/ndt/gfx011 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://academic.oup.com/ndt/article-pdf/32/8/1373/24363907/gfx011.pdf |
| OpenAlex ID | https://openalex.org/W2599499085 |
| PMID | 28371815 |
| Type | article |
| Year | 2017 |

## Paper authors

- [Xuemei Li](https://scholariq.org/researchers/xuemei-li/)
- [Xinzhou Zhang](https://scholariq.org/researchers/xinzhou-zhang/)
- [Xueqing Yu](https://scholariq.org/researchers/xueqing-yu/)

## Paper journal

- [Nephrology Dialysis Transplantation](https://scholariq.org/journals/nephrology-dialysis-transplantation/)

## Paper primary topic

- [Erythropoietin and Anemia Treatment](https://scholariq.org/topics/erythropoietin-and-anemia-treatment/)

## Paper topics

- [Erythropoietin and Anemia Treatment](https://scholariq.org/topics/erythropoietin-and-anemia-treatment/)
- [Cancer, Hypoxia, and Metabolism](https://scholariq.org/topics/cancer-hypoxia-and-metabolism/)
- [Blood transfusion and management](https://scholariq.org/topics/blood-transfusion-and-management/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.